PHOTO
- Contactless devices will monitor temperature, heart rate, respiratory rate
Abu Dhabi – Etihad Airways, the national airline of the UAE, will partner with Australian company Elenium Automation to trial new technology which allows self-service devices at airports to be used to help identify travellers with medical conditions, potentially including the early stages of COVID-19.
Etihad will be the first airline to trial the technology, which can monitor the temperature, heart rate and respiratory rate of any person using an airport touchpoint such as a check-in or information kiosk, a bag drop facility, a security point or immigration gate.
The Elenium system will automatically suspend the self-service check-in or bag drop process if a passenger’s vital signs indicate potential symptoms of illness. It will then divert to a teleconference or alert qualified staff on site, who can make further assessments and manage travellers as appropriate.
In partnership with Amazon Web Services, Elenium has also developed ‘hands free’ technologies that enable touchless use of self-service devices through voice recognition, further minimising the potential of any viral or bacterial transmission.
Etihad will initially trial the monitoring technology at its hub airport in Abu Dhabi, capital of the UAE, at the end of April and throughout May 2020, initially with a range of volunteers, and, as flights resume, outbound passengers.
Jorg Oppermann, Vice President Hub and Midfield Operations, Etihad Airways, said: “This technology is not designed or intended to diagnose medical conditions. It is an early warning indicator which will help to identify people with general symptoms, so that they can be further assessed by medical experts, potentially preventing the spread of some conditions to others preparing to board flights to multiple destinations.
“It has long been the case that aircraft, with their highly sophisticated air-recycling systems and standards of hygiene are not the transmission vehicle for illnesses. We are testing this technology because we believe it will not only help in the current COVID-19 outbreak, but also into the future, with assessing a passenger’s suitability to travel and thus minimising disruptions. At Etihad we see this is another step towards ensuring that future viral outbreaks do not have the same devastating effect on the global aviation industry as is currently the case.”
Aaron Hornlimann, CEO and Co-Founder of Elenium Automation, said: “We believe this approach is a world first. Elenium has lodged patents for both the automatic detection of illness symptoms at an aviation self-service touchpoint, and touchless self-service technology at an airport. Combined, this would ensure health screenings can become standard across airports, without putting staff in harm with manual processes.
“The system would screen every individual, including multiple people on the same booking. The technology can also be retrofitted into any airport kiosk or bag drop or installed as a desktop system at a passenger processing point such as an immigration desk. We believe the introduction of touchless self-service and automated health screening will encourage passengers to return to travel sooner.”
-Ends-
For more information, contact:
Duty Media Officer, Etihad Aviation Group
Tel: +971 50 818 9596
Email: dutymediaofficer@etihad.ae
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
